Circulating angiogenic cytokines and stem cells in patients with severe chronic ischemic heart disease--indicators of myocardial ischemic burden?
Research output: Contribution to journal › Journal article › Research › peer-review
Angiogenic growth factors and stem cell therapies have demonstrated varying results in patients with chronic coronary artery disease. A reason could be that these mechanisms are already up-regulated due to reduced blood supply to the myocardium. The objective of this study was to examine if plasma concentrations of circulating stem cells and angiogenic cytokines in patients with severe stable chronic coronary artery disease were correlated to the clinical severity of the disease.
| Original language | English |
|---|---|
| Journal | International Journal of Cardiology |
| Volume | 120 |
| Issue number | 2 |
| Pages (from-to) | 181-7 |
| Number of pages | 7 |
| ISSN | 0167-5273 |
| DOIs | |
| Publication status | Published - 21 Aug 2007 |
| Externally published | Yes |
- Adult, Aged, Aged, 80 and over, Antigens, CD34, Antigens, CD45, Biological Markers, Chronic Disease, Cytokines, Enzyme-Linked Immunosorbent Assay, Female, Flow Cytometry, Follow-Up Studies, Humans, Male, Mesenchymal Stromal Cells, Middle Aged, Myocardial Ischemia, Prospective Studies, Radioimmunoassay, Severity of Illness Index, Stem Cells
Research areas
ID: 47744204